96 related articles for article (PubMed ID: 9597680)
1. Quality of life in patients with low-grade non-Hodgkin's lymphoma.
Webster K; Cella D
Oncology (Williston Park); 1998 May; 12(5):697-714; discussion 714, 717, 721. PubMed ID: 9597680
[TBL] [Abstract][Full Text] [Related]
2. Differences in quality of life between non-Hodgkin's lymphoma survivors meeting and not meeting public health exercise guidelines.
Vallance JK; Courneya KS; Jones LW; Reiman T
Psychooncology; 2005 Nov; 14(11):979-91. PubMed ID: 15744764
[TBL] [Abstract][Full Text] [Related]
3. Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi.
Merli F; Bertini M; Luminari S; Mozzana R; Bertè R; Trottini M; Stelitano C; Botto B; Pizzuti M; Quintana G; De Paoli A; Federico M;
Haematologica; 2004 Aug; 89(8):973-8. PubMed ID: 15339681
[TBL] [Abstract][Full Text] [Related]
4. Quality of Life is Similar between Long-term Survivors of Indolent and Aggressive Non-Hodgkin Lymphoma.
Beaven AW; Samsa G; Zimmerman S; Smith SK
Cancer Invest; 2016 Jul; 34(6):279-85. PubMed ID: 27379565
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of non-Hodgkin lymphoma in elderly patients].
Doorduijn JK; Sonneveld P
Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2152-7. PubMed ID: 9550794
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of low-grade non-Hodgkin's lymphoma].
Heinz R; Hopfinger-Limberger G
Wien Klin Wochenschr; 1994; 106(10):321-6. PubMed ID: 8053200
[TBL] [Abstract][Full Text] [Related]
7. An exploratory path model of the relationships between positive and negative adaptation to cancer on quality of life among non-Hodgkin lymphoma survivors.
Bryant AL; Smith SK; Zimmer C; Crandell J; Jenerette CM; Bailey DE; Zimmerman S; Mayer DK
J Psychosoc Oncol; 2015; 33(3):310-31. PubMed ID: 25751114
[TBL] [Abstract][Full Text] [Related]
8. Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma.
Blaes AH; Ma L; Zhang Y; Peterson BA
Leuk Lymphoma; 2011 Nov; 52(11):2105-10. PubMed ID: 21740095
[TBL] [Abstract][Full Text] [Related]
9. The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review.
Oerlemans S; Mols F; Nijziel MR; Lybeert M; van de Poll-Franse LV
Ann Hematol; 2011 Sep; 90(9):993-1004. PubMed ID: 21670973
[TBL] [Abstract][Full Text] [Related]
10. Conventional treatments for non-Hodgkin's lymphoma: the need for new therapies.
Moskowitz CH
J Nucl Med; 1998 Aug; 39(8 Suppl):2S-10S. PubMed ID: 9708564
[TBL] [Abstract][Full Text] [Related]
11. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
12. Current approaches to the treatment of advanced-stage non-Hodgkin's lymphoma.
Rusthoven JJ
CMAJ; 1987 Jan; 136(1):29-36. PubMed ID: 3539298
[TBL] [Abstract][Full Text] [Related]
13. Exploring health-related quality of life among non-Hodgkin's lymphoma survivors after completion of primary treatment: a cross-sectional study in Thailand.
Lekdamrongkul P; Pongthavornkamol K; Molassiotis A; Sriyuktasuth A; Siritanaratkul N; Chansatitporn N
Support Care Cancer; 2021 Nov; 29(11):6511-6522. PubMed ID: 33909148
[TBL] [Abstract][Full Text] [Related]
14. Experiences of and preferences for self-management among low grade non-Hodgkin's lymphoma survivors: A qualitative interview study.
Pallin ND; O'Connor M; Gannon A; Browne J; Cahill MR; O'Shea D
Eur J Oncol Nurs; 2023 Oct; 66():102378. PubMed ID: 37506608
[TBL] [Abstract][Full Text] [Related]
15. Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma.
Morris EC; Mackinnon S
Best Pract Res Clin Haematol; 2005 Mar; 18(1):129-42. PubMed ID: 15694189
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation.
Fu P; van Heeckeren WJ; Wadhwa PD; Bajor DJ; Creger RJ; Xu Z; Cooper BW; Laughlin MJ; Gerson SL; Koç ON; Lazarus HM
Contemp Clin Trials; 2008 Mar; 29(2):157-64. PubMed ID: 17707140
[TBL] [Abstract][Full Text] [Related]
17. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
Laport GF; Williams SF
Semin Oncol; 1998 Aug; 25(4):503-17. PubMed ID: 9728600
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL).
Uyl-de Groot CA; Hagenbeek A; Verdonck LF; Löwenberg B; Rutten FF
Bone Marrow Transplant; 1995 Sep; 16(3):463-70. PubMed ID: 8535321
[TBL] [Abstract][Full Text] [Related]
19. Conventional allograft and autograft in low grade lymphoma.
Avivi I; Goldstone AH
Best Pract Res Clin Haematol; 2005 Mar; 18(1):113-28. PubMed ID: 15694188
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin's lymphoma in the elderly: the impact of advanced age on therapeutic options and clinical results.
Orlandi E; Lazzarino M; Brusamolino E; Castelli G; Pagnucco G; Morra E; Bernasconi C
Haematologica; 1991; 76(3):204-8. PubMed ID: 1743590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
